This is a prospective, non-randomized, observational, multicentre (5 sites) study in which subjects that have surgically-correctable Stress Urinary Incontinence undergo a TVT SECUR operative procedure. The study will collect preoperative urologic testing, medical history, and subject quality of life patient questionnaires, Intraoperative procedural data will be collected. Postoperative complications, urologic, testing, and subject questionnaires will be collected at intervals up to 24 months. The anatomic position of the device will be characterize by transvaginal ultrasound testing. To determine the rate and/or improvement rate of patients who have received the Gynecare Secur device after 12 months and after 24 months.
Study Type
OBSERVATIONAL
Enrollment
125
Implant of the Gynecare TVT Secur
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
The primary endpoints are the cure/improvement rate in the cohort at 12 months.
Time frame: 12 months
Distribution of percentage of subjects having a decrease of pad weight as compared to baseline
Time frame: 24 months
Decrease in number of pads used within a 24-hour period as compared to baseline
Time frame: 24 months
Change in patient questionnaires from baseline
Time frame: 24 months
Change in the sling position on transvaginal ultrasound
Time frame: 24 months
Cure/improvement rate at 24 months
Time frame: 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.